Evaluation oral potassium diclofenac effectiveness in pain control of patients with isolated and acute limb trauma

Comparison between effectiveness of oral potassium diclofenac and intravenous acetaminophen in pain management of patients with acute, isolated and closed limb trauma who comes to emergency ward

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201703018872N11

Enrollment

Registered

2017-07-17

Start date

2017-08-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: lower limb trauma. Condition 2: upper limb trauma. Condition 3: wrist and hand trauma. Condition 4: elbow and shoulder trauma. Condition 5: pelvic and thigh trauma. Condition 6: foot trauma. s92-0 s62-0 s62-0 s42-0 s72-0 s92-0

Interventions

First group will receive oral potassium diclofenac ( 50 mg tablet of potassium diclofenac) and second group will receive intravenous acetaminophen( 1 gram in 500 cc of normal saline in 20 min).

Treatment - Drugs

First group will receive oral potassium diclofenac ( 50 mg tablet of potassium diclofenac) and second group will receive intravenous acetaminophen( 1 gram in 500 cc of normal saline in 20 min)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: isolated and closed limb trauma; age>18; pain score> 3( pain score) ;consent to participation in the study. Exclusion Criteria: cardiovascular instability; recent analgesic consumption; drug addiction; intravenous opioid administration by prehospital emergency staff or triage nurse; oral intake intolerance; decreased level of consciousness; dementia; multiple trauma, open limb fractures; language barrier.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Evaluation of pain severity. Timepoint: before intervention and then 5, 15, 30, 60 min and 4 hour after intervention. Method of measurement: VAS.	—

Secondary

Measure	Time frame
Patient satisfaction. Timepoint: after completion on intervention. Method of measurement: patient claim.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Momeni

Tehran University of Medical Sciences

mahdi129@yahoo.com+98 21 8490 2717

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026